On February 11, 2011, Aptalis completed the acquisition of Eurand N.V., a global specialty pharmaceutical company with operating units in the United States and Europe. The new company began operations on February 14, 2011, under the name Aptalis.

To support our new operating model and business moving forward, nine executive positions reporting to Frank Verwiel, M.D. President and Chief Executive Officer were announced in March. The newly-named leaders who comprise our new Management Team (MT) for the combined organization are below.

 

Frank Verwiel, M.D. President and Chief Executive Officer Jean Louis Anspach President, International Specialty Pharmaceuticals Robert Becker, Ph.D. Chief Research Officer Richard DeVleeschouwer Senior Vice President and Chief Human Resources Officer John Fraher President, Aptalis Steve Gannon Senior Vice President, Chief Financial Officer and Treasurer David W. Mims President, US Specialty Pharmaceuticals Theresa Stevens Senior Vice President and Chief Corporate Development Officer Ruth Thieroff-Ekerdt, M.D. Chief Medical Officer

 

© 2011 Aptalis. All rights reserved.

Site Map   |   Terms & Conditions   |   U.S. Commercial Compliance Policy   |   Business Ethics and Conduct Code